Partners and Network

For the benefit of its customers, Protagen AG cultivates strategic partnerships with companies and research institutes. Beyond an intensive know-how exchange, Protagen AG actively develops technologies that are ready for commercial applications.

Strategic Partners

Vela pharmazeutische Entwicklung und Laboranalytik GmbH, Vienna, Austria
Charles River Biopharmaceutical Services, US, Germany, Ireland, Scotland
instrAction GmbH, Ludwigshafen, Germany

Commercial Partners

Serva Electrophoresis GmbH, Heidelberg, Germany
Mikrogen GmbH, Neuried, Germany
Zelle Biotechnology, Mumbai, India
TS DYNE Co., Ltd., Seoul, South Korea
Bionamics GmbH, Kiel, Germany
Scienion AG, Dortmund, Germany

Research Networks

University of Innsbruck, Austria, Urology Clinic (Univ Prof. Mag. Dr. Helmut Klocker)
University of Duisburg-Essen, Germany, Clinic for Psychiatry and Psychotherapy (Prof.Dr. J. Wiltfang )
Johns Hopkins Medical School, Dep. Of Urology (Prof. Alan Partin)
Accelerated Cure Project for Multiple Sclerosis (Hollie Schmidt, VP of Scientific Operations)
Technical University Munich, University Hospital Klinikum rechts der Isar, Department of Neurology (Univ. Prof. Dr. Bernhard Hemmer)
University of Innsbruck, Austria, Center of Gynecology, Department of Gynecology and Obstetrics, Laboratory for Clinical Biochemistry (Priv.-Doz. Mag. Dr. Heidi Fiegl
European Tumor Sample Institute (ETSI-med) GmbH, Hennigsdorf, Germany
Blutspendedienst des Bayrischen Roten Kreuzes GmbH, München, Germany
University of Mainz, Germany, Dermatology Clinic (Prof. Dr. Helmut Jonuleit)
University of Bochum, Germany, Medical Proteome Center (Prof. Helmut E. Meyer)
University of Bochum, Germany, Neurological Clinic (Prof. Gold, Dr. Andrew Chan)
Klinikum Lüdenscheid, Germany, Neurological Department (Dr. S. Schimrigk)
University of Düsseldorf, Germany, Rheumatology Clinic (Prof. M. Schneider)
University of Zuerich, Switzerland, Neurological Clinic (Prof. R. Martin)
University of Ulm, Germany, Neurological Clinic (Prof. H. Tumani)
Karolinska Institutet, Stockholm, Sweden, Department of Clinical Neuroscience (Prof. T Olsson, Dr. M. Khademi)
Institute for Neuroimmunology and Clinical Multiple Sclerosis (MS) Research, Hamburg, Germany (Prof. Heesen, Prof. Martin) 
University of Basel, Switzerland, Department of Clinical Neuroimmunology, (Dr. J. Kuhle)
Medical University of Graz, Austria, Division of Endocrinology and Metabolism (Univ.-Prof. Dr.med.univ.Thomas Pieber)
Medical University of Vienna, Austria, Department of Gastroenterology and Hepatology (Univ.-Prof. Dr.med.univ Michael Trauner)
Charité - Universitätsmedizin Berlin, Germany, Department of Uroloy (PD Dr. med. Carsten Stephan)
University Hospital of Münster, Germany, Department of Urology (Prof. Dr. Axel Semjonow)
University Hospital Hamburg-Eppendorf, Germany, Martini-Klinik (Prof. Dr. Alexander Haese)

Protagen is actively involved in the following academic projects:

EUCAAD (EU Consortium for Anticancer Antibody Development)
LipidomicNet - EU Framework VII project
Oncotyrol - Medical University Innsbruck, Consortium for Personalized Medicine
BioPersMed (Biomarkers for personalised medicine in common metabolic disorders, Medical University of Graz, Austria)
ProCell

Protagen is member of:

DECHEMA
Bio Deutschand 
GFID (Gesellschaft zur Förderung der Immundiagnostik) 
EPMA (European Association for Predictive, Preventive & Personalized Medicine) 
CLIB2021 - Cluster for Industrial Biotechnology
Association for the Advancement of Immune Diagnostics e.V.